Published in Cancer Weekly, April 8th, 2008
"A reference (REF) IMRT plan was generated based on a standard treatment planning protocol, with a set of user-defined dose constraints for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.